Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00181012
Status:
UNKNOWN
Last Update Posted:
2007-09-19
First Post:
2005-09-13
Brief Title:
Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Study Overview
Official Title:
Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics Efficacy Study in Adults and Children Randomized Prospective Study With Direct Individual Benefit
Status:
UNKNOWN
Status Verified Date:
2006-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the benefit of lidocaine perfusion in cancer related visceral pain resistant to morphinics It is an efficacy study in adults and children and a randomized prospective study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CSET 20031054 | None | None | None |